Seres Therapeutics Stock Price History
| MCRB Stock | USD 0.73 0.05 6.41% |
Below is the normalized historical share price chart for Seres Therapeutics extending back to June 26, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Seres Therapeutics stands at 0.73, as last reported on the 20th of March, with the highest price reaching 0.77 and the lowest price hitting 0.71 during the day.
If you're considering investing in Seres Stock, it is important to understand the factors that can impact its price. Seres Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0477, which indicates the firm had a -0.0477 % return per unit of risk over the last 3 months. Seres Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Seres Therapeutics' Coefficient Of Variation of (5,459), risk adjusted performance of (0.01), and Variance of 26.35 to confirm the risk estimate we provide.
At present, Seres Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 181.7 K, whereas Total Stockholder Equity is forecasted to decline to about 13.1 M. . At present, Seres Therapeutics' Price Earnings Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 9.84, whereas Price To Sales Ratio is forecasted to decline to 1.21. Seres Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of June 2015 | 200 Day MA 0.8713 | 50 Day MA 0.7891 | Beta 2.173 |
Seres |
Sharpe Ratio = -0.0477
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MCRB |
Estimated Market Risk
| 5.32 actual daily | 47 53% of assets are more volatile |
Expected Return
| -0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Seres Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Seres Therapeutics by adding Seres Therapeutics to a well-diversified portfolio.
Price Book 9.8614 | Enterprise Value Ebitda (2.07) | Price Sales 390.2706 | Shares Float 128.5 M | Wall Street Target Price 3.824 |
Seres Therapeutics Stock Price History Chart
There are several ways to analyze Seres Stock price data. The simplest method is using a basic Seres candlestick price chart, which shows Seres Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 23, 2024 | 0.97 |
| Lowest Price | March 13, 2025 | 0.64 |
Seres Therapeutics March 20, 2025 Stock Price Synopsis
Various analyses of Seres Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Seres Stock. It can be used to describe the percentage change in the price of Seres Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Seres Stock.| Seres Therapeutics Price Daily Balance Of Power | (0.83) | |
| Seres Therapeutics Price Action Indicator | (0.04) | |
| Seres Therapeutics Accumulation Distribution | 77,882 | |
| Seres Therapeutics Price Rate Of Daily Change | 0.94 |
Seres Therapeutics March 20, 2025 Stock Price Analysis
Seres Stock Price History Data
The price series of Seres Therapeutics for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 0.33 with a coefficient of variation of 8.6. The daily prices for the period are spread out with arithmetic mean of 0.81. The median price for the last 90 days is 0.82.| Open | High | Low | Close | Volume | ||
| 03/20/2025 | 0.77 | 0.77 | 0.71 | 0.73 | 999,487 | |
| 03/19/2025 | 0.77 | 0.79 | 0.72 | 0.78 | 584,801 | |
| 03/18/2025 | 0.74 | 0.81 | 0.72 | 0.75 | 1,335,040 | |
| 03/17/2025 | 0.71 | 0.74 | 0.69 | 0.74 | 685,941 | |
| 03/14/2025 | 0.65 | 0.69 | 0.64 | 0.69 | 813,357 | |
| 03/13/2025 | 0.68 | 0.70 | 0.62 | 0.64 | 1,681,064 | |
| 03/12/2025 | 0.72 | 0.75 | 0.68 | 0.69 | 879,264 | |
| 03/11/2025 | 0.71 | 0.75 | 0.70 | 0.72 | 435,153 | |
| 03/10/2025 | 0.77 | 0.78 | 0.72 | 0.73 | 497,859 | |
| 03/07/2025 | 0.73 | 0.77 | 0.72 | 0.77 | 503,796 | |
| 03/06/2025 | 0.75 | 0.76 | 0.72 | 0.74 | 269,149 | |
| 03/05/2025 | 0.69 | 0.77 | 0.68 | 0.76 | 960,773 | |
| 03/04/2025 | 0.72 | 0.73 | 0.63 | 0.67 | 2,589,408 | |
| 03/03/2025 | 0.76 | 0.78 | 0.73 | 0.75 | 513,370 | |
| 02/28/2025 | 0.72 | 0.77 | 0.72 | 0.76 | 735,052 | |
| 02/27/2025 | 0.79 | 0.79 | 0.72 | 0.73 | 429,811 | |
| 02/26/2025 | 0.76 | 0.79 | 0.72 | 0.75 | 1,113,085 | |
| 02/25/2025 | 0.79 | 0.80 | 0.76 | 0.78 | 698,573 | |
| 02/24/2025 | 0.81 | 0.82 | 0.77 | 0.79 | 376,386 | |
| 02/21/2025 | 0.81 | 0.83 | 0.80 | 0.80 | 908,168 | |
| 02/20/2025 | 0.82 | 0.85 | 0.80 | 0.81 | 652,953 | |
| 02/19/2025 | 0.82 | 0.85 | 0.82 | 0.83 | 293,268 | |
| 02/18/2025 | 0.83 | 0.86 | 0.81 | 0.83 | 1,230,331 | |
| 02/14/2025 | 0.84 | 0.86 | 0.83 | 0.83 | 494,426 | |
| 02/13/2025 | 0.83 | 0.84 | 0.80 | 0.84 | 448,220 | |
| 02/12/2025 | 0.81 | 0.84 | 0.79 | 0.82 | 913,783 | |
| 02/11/2025 | 0.77 | 0.81 | 0.75 | 0.80 | 896,502 | |
| 02/10/2025 | 0.79 | 0.80 | 0.77 | 0.79 | 851,825 | |
| 02/07/2025 | 0.78 | 0.79 | 0.77 | 0.78 | 754,638 | |
| 02/06/2025 | 0.78 | 0.84 | 0.78 | 0.78 | 1,065,698 | |
| 02/05/2025 | 0.81 | 0.83 | 0.79 | 0.79 | 792,535 | |
| 02/04/2025 | 0.81 | 0.84 | 0.80 | 0.81 | 850,267 | |
| 02/03/2025 | 0.85 | 0.87 | 0.81 | 0.83 | 836,766 | |
| 01/31/2025 | 0.87 | 0.88 | 0.83 | 0.84 | 753,166 | |
| 01/30/2025 | 0.81 | 0.88 | 0.81 | 0.86 | 1,012,846 | |
| 01/29/2025 | 0.82 | 0.84 | 0.79 | 0.81 | 937,573 | |
| 01/28/2025 | 0.83 | 0.86 | 0.80 | 0.81 | 772,080 | |
| 01/27/2025 | 0.85 | 0.92 | 0.82 | 0.84 | 1,756,940 | |
| 01/24/2025 | 0.89 | 0.93 | 0.85 | 0.86 | 1,279,183 | |
| 01/23/2025 | 0.89 | 0.95 | 0.84 | 0.89 | 2,555,259 | |
| 01/22/2025 | 0.74 | 0.95 | 0.74 | 0.91 | 11,393,150 | |
| 01/21/2025 | 0.77 | 0.77 | 0.72 | 0.73 | 1,211,148 | |
| 01/17/2025 | 0.74 | 0.79 | 0.74 | 0.77 | 830,262 | |
| 01/16/2025 | 0.75 | 0.80 | 0.71 | 0.74 | 10,654,050 | |
| 01/15/2025 | 0.78 | 0.81 | 0.75 | 0.78 | 1,126,195 | |
| 01/14/2025 | 0.81 | 0.83 | 0.75 | 0.77 | 2,556,758 | |
| 01/13/2025 | 0.83 | 0.84 | 0.80 | 0.82 | 1,064,488 | |
| 01/10/2025 | 0.90 | 0.91 | 0.83 | 0.84 | 751,810 | |
| 01/08/2025 | 0.85 | 0.88 | 0.84 | 0.85 | 707,718 | |
| 01/07/2025 | 0.91 | 0.94 | 0.85 | 0.87 | 1,376,448 | |
| 01/06/2025 | 0.89 | 0.95 | 0.89 | 0.91 | 1,527,967 | |
| 01/03/2025 | 0.83 | 0.91 | 0.82 | 0.91 | 1,531,545 | |
| 01/02/2025 | 0.85 | 0.85 | 0.81 | 0.84 | 1,090,382 | |
| 12/31/2024 | 0.85 | 0.85 | 0.80 | 0.83 | 1,538,588 | |
| 12/30/2024 | 0.88 | 0.89 | 0.82 | 0.83 | 2,760,568 | |
| 12/27/2024 | 0.93 | 0.93 | 0.87 | 0.89 | 1,320,848 | |
| 12/26/2024 | 0.94 | 0.97 | 0.92 | 0.92 | 886,345 | |
| 12/24/2024 | 0.95 | 0.99 | 0.95 | 0.96 | 938,824 | |
| 12/23/2024 | 0.92 | 1.00 | 0.92 | 0.97 | 3,029,037 | |
| 12/20/2024 | 0.93 | 0.96 | 0.92 | 0.92 | 2,789,337 | |
| 12/19/2024 | 0.90 | 0.97 | 0.87 | 0.92 | 2,663,890 |
About Seres Therapeutics Stock history
Seres Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Seres is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Seres Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Seres Therapeutics stock prices may prove useful in developing a viable investing in Seres Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 155.4 M | 163.2 M | |
| Net Loss | -225.1 M | -213.9 M |
Seres Therapeutics Stock Technical Analysis
Seres Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Seres Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Seres Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Seres Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Seres to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | 0.0884 | |||
| Total Risk Alpha | 0.3293 | |||
| Treynor Ratio | (0.04) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Seres Stock analysis
When running Seres Therapeutics' price analysis, check to measure Seres Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seres Therapeutics is operating at the current time. Most of Seres Therapeutics' value examination focuses on studying past and present price action to predict the probability of Seres Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seres Therapeutics' price. Additionally, you may evaluate how the addition of Seres Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |